Development of research priorities in paediatric pain and palliative care

Christina Liossi1, Anna-Karenia Anderson2, Richard F Howard3

  • 1Department of Psychology, University of Southampton, Southampton, UK; Department of Paediatric Psychology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Insights

This study prioritized key research questions in pediatric pain and palliative care. Top priorities include gabapentin for chronic pain, NSAIDs for post-operative pain in preschoolers, and opioid formulations for acute home pain.

Area of Science:

  • Pediatric Pain Management
  • Palliative Care Research
  • Healthcare Priority Setting

Background:

  • Effective priority setting is crucial for high-quality healthcare research.
  • Paediatric pain and palliative care research requires focused direction.
  • Identifying and prioritizing clinical therapeutic uncertainties is essential.

Purpose of the Study:

  • To prioritize clinical therapeutic uncertainties in paediatric pain and palliative care.
  • To inform the future research agenda in the UK.
  • To raise the profile of paediatric pain and palliative care.

Main Methods:

  • Clinical therapeutic uncertainties were identified and formatted into patient, intervention, comparison, and outcome (PICO) statements.
  • A modified Nominal Group Technique was used for prioritization.
  • Participants included 11 healthcare professionals and one parent representative from the NIHR CRN-Children.

Main Results:

  • Top priorities included the safety and efficacy of gabapentin for chronic neuropathic pain.
  • Other key priorities involved IV NSAIDs for post-operative pain in preschoolers and different opioid formulations for home pain management.
  • Long-term effects of psychological interventions and pharmacological interventions for palliative care were also identified as high priorities.

Conclusions:

  • The study successfully identified and prioritized critical research questions in paediatric pain and palliative care.
  • Results are available in the UK Database of Uncertainties about the Effects of Treatments (DUETS).
  • Increased engagement with priority-setting processes is encouraged for clinicians and stakeholders.